C26 cancer-induced muscle wasting Is IKKb-dependent and NF-kappaB-independent

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Cornwell, Evangeline W ^a   Mirbod, Azadeh ^a   Wu, Chia Ling ^a   Kandarian, Susan C ^a   Jackman, Robert W ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN P100; PROTEIN P52; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CACHEXIA; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; MALE; MICROARRAY ANALYSIS; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; RNA ISOLATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; CACHEXIA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ONTOLOGY; I-KAPPA B KINASE; MALE; MICE; MUSCLE, SKELETAL; MUSCULAR ATROPHY; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTOME;

EID: 84900404229     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087776     Document Type: Article

References (48)

1. Tisdale MJ (2009) Mechanisms of cancer cachexia. Physiol Rev 89: 381-410.
2. Argiles JM, Busquets S, Lopez-Soriano FJ (2005) The pivotal role of cytokines in muscle wasting during cancer. Int J Biochem Cell Biol 37: 1609-1619. (Pubitemid 40719640)
3. Baracos VE (2003) Overview on metabolic adaptation to stress. Nestle Nutr Workshop Ser Clin Perform Programme 8: 1-9; discussion 10-13.
4. Di Marco S, Cammas A, Lian XJ, Kovacs EN, Ma JF, et al. (2012) The translation inhibitor pateamine A prevents cachexia-induced muscle wasting in mice. Nat Commun 3: 1-12.
5. Cai D, Frantz JD, Tawa NE, Jr., Melendez PA, Oh BC, et al. (2004) IKKbeta/ NF-kappaB activation causes severe muscle wasting in mice. Cell 119: 285-298. (Pubitemid 39360909)
6. Acharyya S, Butchbach ME, Sahenk Z, Wang H, Saji M, et al. (2005) Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell 8: 421-432. (Pubitemid 41579836)
7. Wyke SM, Russell ST, Tisdale MJ (2004) Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation. Br J Cancer 91: 1742-1750. (Pubitemid 39546149)
8. Rhoads MG, Kandarian SC, Pacelli F, Doglietto GB, Bossola M (2009) Expression of NF-kappaB and IkappaB proteins in skeletal muscle of gastric cancer patients. Eur J Cancer.
9. Shadfar S, Couch ME, McKinney KA, Weinstein LJ, Yin X, et al. (2011) Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo. Nutr Cancer 63: 749-762.
10. Busquets S, Figueras MT, Fuster G, Almendro V, Moore-Carrasco R, et al. (2004) Anticachectic Effects of Formoterol: A Drug for Potential Treatment of Muscle Wasting. Cancer Res 64: 6725-6731. (Pubitemid 39297935)
11. Van Gammeren D, Damrauer JS, Jackman RW, Kandarian SC (2009) The IkappaB kinases IKKalpha and IKKbeta are necessary and sufficient for skeletal muscle atrophy. Faseb J 23: 362-370.
12. Dona M, Sandri M, Rossini K, Dell'Aica I, Podhorska-Okolow M, et al. (2003) Functional in vivo gene transfer into the myofibers of adult skeletal muscle. Biochem Biophys Res Commun 312: 1132-1138. (Pubitemid 37490933)
13. Rossini K, Sandri M, Dona M (2002) High level of gene transfer into adult skeletal muscle bi in vivo direct electroporation. Basic Appl Myol 12: 97-100. (Pubitemid 36631155)
14. Taylor J, Babbs CF, Alzghoul MB, Olsen A, Latour M, et al. (2004) Optimization of ectopic gene expression in skeletal muscle through DNA transfer by electroporation. BMC Biotechnol 4: 11.
15. Schertzer JD, Plant DR, Lynch GS (2006) Optimizing plasmid-based gene transfer for investigating skeletal muscle structure and function. Mol Ther 13: 795-803.
16. Judge AR, Koncarevic A, Hunter RB, Liou HC, Jackman RW, et al. (2007) Role for IkappaBalpha, but not c-Rel, in skeletal muscle atrophy. Am J Physiol Cell Physiol 292: C372-382. (Pubitemid 46115145)
17. Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS, Jr. (2000) NF-kappaB- induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289: 2363-2366.
18. Li H, Mittal A, Paul PK, Kumar M, Srivastava DS, et al. (2009) Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB- inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy. J Biol Chem 284: 4439-4450.
19. Kumar A, Boriek AM (2003) Mechanical stress activates the nuclear factorkappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy. FASEB J 17: 386-396. (Pubitemid 36292954)
20. Koncarevic A, Jackman RW, Kandarian SC (2007) The ubiquitin-protein ligase Nedd4 targets Notch1 in skeletal muscle and distinguishes the subset of atrophies caused by reduced muscle tension. FASEB J 21: 427-437. (Pubitemid 46213490)
21. Wu CL, Kandarian SC, Jackman RW (2011) Identification of genes that elicit disuse muscle atrophy via the transcription factors p50 and Bcl-3. PLoS One 6: e16171.
22. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193. (Pubitemid 36181903)
23. Allan SE, Passerini L, Bacchetta R, Crellin N, Dai M, et al. (2005) The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest 115: 3276-3284. (Pubitemid 41567592)
24. Giannopoulou EG, Elemento O (2011) An integrated ChIP-seq analysis platform with customizable workflows. BMC Bioinformatics 12: 277.
25. Salmon-Divon M, Dvinge H, Tammoja K, Bertone P (2010) PeakAnalyzer: genome-wide annotation of chromatin binding and modification loci. BMC Bioinformatics 11: 415.
26. Leung TH, Hoffmann A, Baltimore D (2004) One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers. Cell 118: 453-464. (Pubitemid 39485665)
27. Yamaki T, Wu CL, Gustin M, Lim J, Jackman RW, et al. (2012) Rel A/p65 is required for cytokine-induced myotube atrophy. Am J Physiol Cell Physiol 303: C135-142.
28. Girgenrath M, Beermann ML, Vishnudas VK, Homma S, Miller JB (2009) Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy. Ann Neurol 65: 47-56.
29. Hunter RB, Kandarian SC (2004) Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy. J Clin Invest 114: 1504-1511. (Pubitemid 40385580)
30. Jackman RW, Rhoads MG, Cornwell E, Kandarian SC (2009) Microtubulemediated NF-kappaB activation in the TNF-alpha signaling pathway. Exp Cell Res 315: 3242-3249.
31. Bonetto A, Aydogdu T, Kunzevitzky N, Guttridge DC, Khuri S, et al. (2011) STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS One 6: e22538.
32. Barish GD, Yu RT, Karunasiri M, Ocampo CB, Dixon J, et al. (2010) Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response. Genes Dev 24: 2760-2765.
33. Kasowski M, Grubert F, Heffelfinger C, Hariharan M, Asabere A, et al. (2010) Variation in transcription factor binding among humans. Science 328: 232-235.
34. Jackman RW, Wu CL, Kandarian SC (2012) The ChIP-seq-defined networks of Bcl-3 gene binding support its required role in skeletal muscle atrophy. PLoS One 7: e51478.
35. Bakkar N, Wang J, Ladner KJ, Wang H, Dahlman JM, et al. (2008) IKK/NFkappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J Cell Biol 180: 787-802. (Pubitemid 351397778)
36. Enwere EK, Holbrook J, Lejmi-Mrad R, Vineham J, Timusk K, et al. (2012) TWEAK and cIAP1 regulate myoblast fusion through the noncanonical NFkappaB signaling pathway. Sci Signal 5: ra75.
37. Bhatnagar S, Panguluri SK, Gupta SK, Dahiya S, Lundy RF, et al. (2010) Tumor necrosis factor-alpha regulates distinct molecular pathways and gene networks in cultured skeletal muscle cells. PLoS One 5: e13262.
38. Xing Y, Zhou F, Wang J (2013) Subset of genes targeted by transcription factor NF-kappaB in TNFalpha-stimulated human HeLa cells. Funct Integr Genomics 13: 143-154.
39. Hunter RB, Stevenson E, Koncarevic A, Mitchell-Felton H, Essig DA, et al. (2002) Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy. FASEB J 16: 529-538. (Pubitemid 34273236)
40. Scheidereit C (2006) IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25: 6685-6705.
41. Comb WC, Cogswell P, Sitcheran R, Baldwin AS (2011) IKK-dependent, NF-kappaB- independent control of autophagic gene expression. Oncogene 30: 1727-1732.
42. Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, et al. (2004) IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117: 225-237. (Pubitemid 38496242)
43. Gringhuis SI, Garcia-Vallejo JJ, van Het Hof B, van Dijk W (2005) Convergent actions of I kappa B kinase beta and protein kinase C delta modulate mRNA stability through phosphorylation of 14-3-3 beta complexed with tristetraprolin. Mol Cell Biol 25: 6454-6463. (Pubitemid 41023221)
44. Lee S, Andrieu C, Saltel F, Destaing O, Auclair J, et al. (2004) IkappaB kinase beta phosphorylates Dok1 serines in response to TNF, IL-1, or gamma radiation. Proc Natl Acad Sci U S A 101: 17416-17421. (Pubitemid 39657419)
45. Jackman RW, Cornwell EW, Wu CL, Kandarian SC (2013) Nuclear factorkappaB signalling and transcriptional regulation in skeletal muscle atrophy. Exp Physiol 98: 19-24.
46. Zhang G, Jin B, Li YP (2011) C/EBPbeta mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting. EMBO J 30: 4323- 4335.
47. Reed SA, Sandesara PB, Senf SM, Judge AR (2012) Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy. FASEB J 26: 987-1000.
48. Bonetto A, Aydogdu T, Jin X, Zhang Z, Zhan R, et al. (2012) JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am J Physiol Endocrinol Metab 303: E410-21